Target intelligence / Profile preview

Eukaryotic translation initiation factor 2 subunit 2 beta pseudogene 1 (EIF2S2P1)

Target
EIF2S2P1
Molecular classification
Other (Pseudogene)
01

Overview

This gene is annotated as a *pseudogene* for the beta subunit (subunit 2) of eukaryotic translation initiation factor 2. The canonical, functional gene, **EIF2S2**, encodes a beta subunit critical for translation initiation and has roles in cell growth, stress response, and disease[2][4]. However, **EIF2S2P1** itself does not encode a functional protein and is not regarded as a therapeutic target. Pseudogenes like EIF2S2P1 are usually defective copies of functional genes, retaining similarity to their parental gene but lacking protein-coding ability due to disabling mutations. There is currently no evidence suggesting that EIF2S2P1 directly participates in molecular pathways, diseases, or drug interactions. If you intended to ask about the functional gene **EIF2S2** rather than **EIF2S2P1**, that gene is implicated as a prognostic marker and potential target in cancer research, including glioblastoma and hepatocellular carcinoma[2][4]. If so, clarification is recommended, as the two designations refer to distinct (functional vs. non-coding) genetic loci.

Other names
EIF2S2P

Beyond the preview

Go deeper on Eukaryotic translation initiation factor 2 subunit 2 beta pseudogene 1 (EIF2S2P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eukaryotic translation initiation factor 2 subunit 2 beta pseudogene 1 (EIF2S2P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call